Sherif Mahmoud: Updated Guideline for Antithrombotic-Associated Intracranial Hemorrhage
Sherif Mahmoud, Research Director, Neurosciences Intensive Care Unit, Associate Professor, Associate Dean, Academic at University of Alberta, shared a post on LinkedIn about a recent article he and his colleges co-authored, published in Neurocritical Care, adding:
“Thrilled to share that the new joint guideline update from the Neurocritical Care Society (NCS) and the Society of Critical Care Medicine (SCCM) is now published in Neurocritical Care!
It was a true honor to serve on the multidisciplinary writing panel alongside such an outstanding group of clinicians, researchers, and experts.
Managing acute intracranial hemorrhage in patients on antithrombotic therapy is one of the most high-stakes, time-sensitive challenges in emergency and neurocritical care.
This updated guideline synthesizes the latest evidence to help clinicians navigate complex reversal strategies and decision-making when every minute counts.”
Title: Treatment of Antithrombotic-Associated Intracranial Hemorrhage in Adults: A Focused Guideline Update from the Neurocritical Care Society and the Society of Critical Care Medicine
Authors: Meghan Caylor Vallejo, Lori S. Kennedy, Bradley Dengler, Colleen Barthol, Emilie P. Belley-Cote, Joseph D. Burns, Veda K. Chau, Charlotte Cordonnier, Adam Cuker, Kimia Honarmand, Sherif Hanafy Mahmoud, M. Elizabeth Wilcox, Monisha A. Kumar
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 20:01Anand Gupta: Timing of DOAC Initiation in Newly Diagnosed Atrial Fibrillation
-
Sep 25, 2026, 19:56Steven Fein: A History of Blood Clots Doesn’t Mean a Healthy Pregnancy Is Out of Reach
-
Sep 25, 2026, 19:54Pedro Perez: “Provoked” VTE May Not Always Mean the Risk Disappears When the Provoking Event Does
-
Sep 25, 2026, 19:53Kemal Karaagac: Calcitriol May Reduce Thrombotic Risk in MASLD
-
Sep 25, 2026, 19:52The SINGLE-AF Trial Anticoagulation for Intermediate Stroke Risk – NEJM
-
Sep 25, 2026, 19:49Shinya Goto: DOAC vs Placebo in Intermediate Stroke Risk of AF in Single Country?
-
Sep 25, 2026, 19:47Bryan Cotton: DOACs Versus Nothing When Stroke Risk Is Not Zero
-
Sep 25, 2026, 19:45Selin Yaman Seval: ITP Is More Than a Low Platelet Count
-
Sep 25, 2026, 19:44Cy R. Wilkins: Treating Chemotherapy-Induced Thrombocytopenia Beyond the Platelet Count